Jump to content

HELLP syndrome

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by PrevMedFellow (talk | contribs) at 08:54, 9 January 2012 (Using highly-viewed Breast cancer as model, switched "Diagnosis" & "Pathophysiology" sections. Split Mississippi dx criteria into two. Added material from important Haram et al. 2009 review.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

HELLP syndrome
SpecialtyObstetrics Edit this on Wikidata

HELLP syndrome is a life-threatening obstetric complication usually considered to be a variant or complication of pre-eclampsia.[1] Both conditions usually occur during the later stages of pregnancy, or sometimes after childbirth. "HELLP" is an abbreviation of the three main features of the syndrome:[2]

Signs and symptoms

HELLP usually begins during the third trimester; rarely cases have been reported as early as 23 weeks gestation. Often, a patient who develops HELLP syndrome has already been followed up for pregnancy-induced hypertension (gestational hypertension), or is suspected to develop pre-eclampsia (high blood pressure and proteinuria). Up to 8% of all cases present after delivery.

Women with HELLP syndrome often "do not look very sick."[3] Early symptoms can include:

There can be gradual but marked onset of headaches (30%), blurred vision, and paresthesia (tingling in the extremities). Edema may occur but its absence does not exclude HELLP syndrome. Arterial hypertension is a diagnostic requirement, but may be mild. Rupture of the liver capsule and a resultant hematoma may occur. If the patient has a seizure or coma, the condition has progressed into full-blown eclampsia.

Disseminated intravascular coagulation is also seen in about 20% of all women with HELLP syndrome,[5] and in 84% when HELLP is complicated by acute renal failure.[6] Pulmonary edema is found in 6% of all women with HELLP syndrome,[5] and in 44% when HELLP is complicated by acute renal failure.[6]

Patients who present with symptoms of HELLP can be misdiagnosed in the early stages, increasing the risk of liver failure and morbidity.[7] Rarely, post caesarean patients may present in shock condition mimicking either pulmonary embolism or reactionary haemorrhage.

Pathophysiology

The exact cause of HELLP is unknown, but general activation of the coagulation cascade is considered the main underlying problem. Fibrin forms crosslinked networks in the small blood vessels. This leads to a microangiopathic hemolytic anemia: the mesh causes destruction of red blood cells as if they were being forced through a strainer. Additionally, platelets are consumed. As the liver appears to be the main site of this process, downstream liver cells suffer ischemia, leading to periportal necrosis. Other organs can be similarly affected. HELLP syndrome leads to a variant form of disseminated intravascular coagulation (DIC), leading to paradoxical bleeding, which can make emergency surgery a serious challenge.

Diagnosis and classification

HELLP syndrome can be difficult to diagnose due to the variability of symptoms among patients (frequently patients have no symptoms other than general abdominal pain), and early diagnosis is key in reducing morbidity. If not treated in a timely manner, a mother can become critically ill or die due to liver rupture/hemorrhaging or cerebral edema.

In a patient with possible HELLP syndrome, a batch of blood tests is performed: a full blood count, liver enzymes, renal function and electrolytes and coagulation studies. Often, fibrin degradation products (FDPs) are determined, which can be elevated. Lactate dehydrogenase is a marker of hemolysis and is elevated (>600 U/liter). Proteinuria is present but can be mild.

In one 1995 study, a positive D-dimer test in the presence of preeclampsia was reported to be predictive of patients who will develop HELLP syndrome.[7][8]

The diagnostic criteria for and subtypes of HELLP vary across studies, which "makes comparison of published data difficult."[1] The classifications include:

  • Criteria developed at the University of Tennessee:[4][9]
  • Criteria developed at the University of Mississippi, as of 1999:[10]
    • "The diagnosis of HELLP syndrome required the presence of thrombocytopenia (perinatal platelet nadir ≤150,000 cells/μL), evidence of hepatic dysfunction (increased aspartate aminotransferase level of ≥40 IU/L, increased alanine aminotransferase level of ≥40 IU/L, or both, with increased lactate dehydrogenase [LDH] level of ≥600 IU/L), and evidence of hemolysis (increased LDH level, progressive anemia)...."
    • "Class 1 HELLP syndrome featured severe thrombocytopenia with a platelet nadir of ≤50,000 cells/μL, class 2 HELLP syndrome featured moderate thrombocytopenia with a platelet nadir between >50,000 and ≤100,000 cells/μL, and class 3 HELLP syndrome featured mild thrombocytopenia with a platelet nadir between >100,000 and ≤150,000 cells/μL."
  • Criteria developed at the University of Mississippi, as of 2006: "For a patient to merit a diagnosis of HELLP syndrome, class 1 requires severe thrombocytopenia (platelets ≤50,000/μL), evidence of hepatic dysfunction (AST [aspartate aminotransferase] and/or ALT [alanine aminotransferase] ≥70 IU/L), and evidence suggestive of hemolysis (total serum LDH ≥600 IU/L); class 2 requires similar criteria except thrombocytopenia is moderate (>50,000 to ≤100,000/μL); and class 3 includes patients with mild thrombocytopenia (platelets >100,000 but ≤150,000/μL), mild hepatic dysfunction (AST and/or ALT ≥40 IU/L), and hemolysis (total serum LDH ≥600 IU/L)."[11]

Treatment

The only effective treatment is prompt delivery of the baby. Several medications have been investigated for the treatment of HELLP syndrome, but evidence is conflicting as to whether magnesium sulfate decreases the risk of seizures and progress to eclampsia. The DIC is treated with fresh frozen plasma to replenish the coagulation proteins, and the anemia may require blood transfusion. In mild cases, corticosteroids and antihypertensives (labetalol, hydralazine, nifedipine) may be sufficient. Intravenous fluids are generally required. Hepatic hemorrhage can be treated with embolization as well if life-threatening bleeding ensues.

The University of Mississippi standard protocol for HELLP includes corticosteroids.[12] However, a 2009 review found "no conclusive evidence" supporting corticosteroid therapy,[1] and a 2010 systematic review by the Cochrane Collaboration also found "no clear evidence of any effect of corticosteroids on substantive clinical outcomes" either for the mothers or for the newborns,[13]

Prognosis

The outcome for mothers with HELLP syndrome is generally good. With treatment, maternal mortality is about 1 percent. However complications have been observed, including placental abruption, acute renal failure, subcapsular liver hematoma, and retinal detachment.[5]

Epidemiology

Its incidence is reported as 0.5-0.9% of all pregnancies, and 10-20% of women with severe preeclampsia.[1] HELLP usually occurs in Caucasian women over the age of 25.[7]

History

HELLP syndrome was identified as a distinct clinical entity (as opposed to severe pre-eclampsia) by Dr. Louis Weinstein in 1982.[2] In a 2005 article, Weinstein wrote that the unexplained postpartum death of a woman who had hemolysis, abnormal liver function, thrombocytopenia, and hypoglycemia motivated him to review the medical literature and to compile information on similar patients.[3] He noted that cases with features of HELLP had been reported as early as 1954.[3][14]

See also

References

  1. ^ a b c d Haram K, Svendsen E, Abildgaard U (2009). "The HELLP syndrome: clinical issues and management. A review" (PDF). BMC Pregnancy Childbirth. 9: 8. doi:10.1186/1471-2393-9-8. PMID 19245695. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
  2. ^ a b Weinstein L (1982). "Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy". Am J Obstet Gynecol. 142 (2): 159–67. PMID 7055180.
  3. ^ a b c d Weinstein L (2005). "It has been a great ride: the history of HELLP syndrome". Am J Obstet Gynecol. 193 (3 Pt 1): 860–3. doi:10.1016/j.ajog.2005.06.058. PMID 16150288. {{cite journal}}: Unknown parameter |month= ignored (help)
  4. ^ a b c d Sibai BM (1990). "The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?". Am J Obstet Gynecol. 162 (2): 311–6. PMID 2309811. {{cite journal}}: Unknown parameter |month= ignored (help)
  5. ^ a b c Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA (1993). "Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)". Am J Obstet Gynecol. 169 (4): 1000–6. PMID 8238109. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  6. ^ a b Sibai BM, Ramadan MK (1993). "Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets". Am J Obstet Gynecol. 168 (6 Pt 1): 1682–7, discussion 1687–90. PMID 8317509. {{cite journal}}: Unknown parameter |month= ignored (help)
  7. ^ a b c Padden MO (1999). "HELLP syndrome: recognition and perinatal management". Am Fam Physician. 60 (3): 829–36, 839. PMID 10498110. {{cite journal}}: Unknown parameter |month= ignored (help)
  8. ^ Neiger R, Trofatter MO, Trofatter KF Jr (1995). "D-dimer test for early detection of HELLP syndrome". South Med J. 88 (4): 416–9. PMID 7716593. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  9. ^ Audibert F, Friedman SA, Frangieh AY, Sibai BM (1996). "Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome". Am J Obstet Gynecol. 175 (2): 460–4. PMID 8765269. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  10. ^ Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG (1999). "The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification". Am J Obstet Gynecol. 180 (6 Pt 1): 1373–84. PMID 10368474. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  11. ^ Martin JN Jr, Rose CH, Briery CM (2006). "Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child". Am J Obstet Gynecol. 195 (4): 914–34. doi:10.1016/j.ajog.2005.08.044. PMID 16631593. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  12. ^ Martin JN, Owens MY, Keiser SD, Parrish MR, Tam Tam KB, Brewer JM, Cushman JL, May WL (2012). "Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity". Hypertens Pregnancy. 31 (1): 79–90. doi:10.3109/10641955.2010.525277. PMID 21219123.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  13. ^ Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T (2010). "Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy". Cochrane Database Syst Rev (9): CD008148. doi:10.1002/14651858.CD008148.pub2. PMID 20824872. {{cite journal}}: Cite has empty unknown parameter: |month= (help)CS1 maint: multiple names: authors list (link)
  14. ^ Pritchard JA, Weisman R Jr, Ratnoff OD, Vosburgh GJ (1954). "Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy". N Engl J Med. 250 (3): 89–98. doi:10.1056/NEJM195401212500301. PMID 13119851. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Retrieved from "https://en.wikipedia.org/w/index.php?title=HELLP_syndrome&oldid=470401393"